TRINITY BIOTECH PLC (TRIB) Operating margin 2015–2024
TRINITY BIOTECH PLC (TRIB) operating margin by fiscal year — reported operating income divided by reported revenue.
-34.4%FY2024 · since FY2015: 13.5% → -34.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -34.4% | +13.2 pp |
| FY2023 | -47.6% | -16.6 pp |
| FY2022 | -30.9% | -35.8 pp |
| FY2021 | 4.9% | +4.8 pp |
| FY2020 | 0.1% | +26.7 pp |
| FY2019 | -26.7% | -5.8 pp |
| FY2018 | -20.8% | +17.1 pp |
| FY2017 | -38.0% | +2.0 pp |
| FY2016 | -40.0% | -53.5 pp |
| FY2015 | 13.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice